Posts

Showing posts with the label FDA

Being Fitter May Help Your Kidneys Age More Slowly, New Study Finds

Image
Your fitness level today could be a clue to how well your kidneys age. A new study from Japan has found that adults with higher cardiorespiratory fitness experienced a slower decline in kidney function over five years — suggesting that staying fit may help protect the kidneys long before any disease appears. The research, published in the November 2026 issue of Medicine & Science in Sports & Exercise, followed 198 adults with healthy kidney function, with a median age of 61.4 years. The team from the University of Tsukuba, led by Shun Yoshikoshi, measured each participant's cardiorespiratory fitness — the body's ability to supply oxygen during sustained activity — using a submaximal cycling test, then tracked their kidney function annually for five years. The results were clear: participants with higher fitness showed a slower decline in kidney function when it was estimated using cystatin C, a blood marker of how efficiently the kidneys filter waste. The link held even...

FDA Orders New Eye Warning on Ozempic, Wegovy and All GLP-1 Drugs Over Rare Vision Risk

Image
The U.S. Food and Drug Administration has ordered a new safety warning on every GLP-1 weight-loss and diabetes drug sold in the United States, after identifying a potential increased risk of a rare eye condition that can cause sudden vision loss. In a Drug Safety Communication issued on November 9, 2026, the FDA said it is requiring manufacturers of all glucagon-like peptide-1 receptor agonists (GLP-1 RAs) to add information about non-arteritic anterior ischemic optic neuropathy, or NAION, to the Warnings and Precautions section of their product labels. NAION, often described as an "eye stroke," is caused by reduced blood flow to the optic nerve. It can cause sudden, painless vision loss in one eye, including blind spots, tunnel vision or distorted colours, and the damage is usually not reversible. The warning covers the full GLP-1 class, including Ozempic, Wegovy and Rybelsus (semaglutide), Mounjaro and Zepbound (tirzepatide), Saxenda and Victoza (liraglutide), and Trulicity...

Popular posts from this blog

Eating Less Protein Could Slow Aging, Major Review of 350 Studies Suggests

Build Muscle, Beat Diabetes: Why Strength Training Is a Powerful Tool for Blood Sugar Control This World Diabetes Day

Your Waist Size May Matter More Than Your Weight, Massive Study of 17 Million Adults Finds